Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2021
Where the money goes
Where each dollar of revenue went, fiscal 2021
- Cost of revenue51¢$74.2K
- Other costs46¢$67.0K
- Interest3¢$3.9K
Out of $145.1K in revenue.3 The company lost money this year.
Financial statements
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenue | $04 | $1.3M5 | $135.1K6 | $99.6K7 | $80.0K8 | $86.7K3 | $145.1K3 |
| Cost of revenue | $945.0K5 | $81.9K6 | $78.2K7 | $67.6K8 | $93.2K3 | $74.2K3 | |
| Gross profit | $331.7K5 | $53.3K6 | $21.4K7 | $12.3K8 | -$6.6K3 | $70.9K3 | |
| Selling, general and admin | $31.2K4 | ||||||
| Operating income | -$31.2K4 | -$1.0M5 | -$1.9M6 | -$1.1M7 | -$538.5K8 | $524.8K3 | $521.3K3 |
| Interest | -$3.0K6 | $3.0K7 | $2.4K8 | $4.3K3 | $3.9K3 | ||
| Income tax | $07 | $08 | $03 | $03 | |||
| Net income | -$31.2K9 | -$1.0M5 | -$1.7M6 | -$1.4M7 | -$496.7K8 | -$396.0K3 | -$499.8K3 |
| Earnings per share | -$1.055 | -$1.216 | -$0.857 | -$0.317 | |||
| Earnings per share (diluted) | -$1.055 | -$1.216 | -$0.857 | -$0.317 | |||
| Shares (weighted, basic) | 160.8M shares3 | ||||||
| Shares (weighted, diluted) | 160.8M shares3 |
| Fiscal year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Cash | $469.6K5 | $518.8K6 | $38.9K7 | $9.1K8 | $61.7K3 | $26.7K3 | $6.5K3 |
| Receivables | $03 | ||||||
| Inventory | $03 | ||||||
| Current assets | $3.5M5 | $428.1K6 | $36.6K7 | $99.0K8 | $50.9K3 | $29.8K3 | |
| Property, plant and equipment | $2.1M3 | ||||||
| Intangible assets | $818.4K3 | ||||||
| Total assets | $1759 | $7.5M5 | $4.4M6 | $3.2M7 | $3.1M8 | $3.0M3 | $2.9M3 |
| Accounts payable | $19.9K3 | ||||||
| Current liabilities | $17.0K9 | $10.8M5 | $9.5M6 | $9.6M7 | $10.0M8 | $10.5M3 | $10.8M3 |
| Total liabilities | $17.0K9 | $10.8M5 | $9.5M6 | $9.6M7 | $10.0M8 | $10.5M3 | $10.8M3 |
| Retained earnings | -$7.6M3 | ||||||
| Shareholders’ equity | -$2.2M5 | -$3.3M5 | -$5.1M7 | -$6.4M8 | -$6.9M3 | -$7.4M3 | -$7.9M3 |
| Shares outstanding | 6.1M shares4 | 100.0M shares5 | 160.8M shares6 | 160.8M shares7 | 160.8M shares8 | 160.8M shares3 | 160.8M shares3 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Compare GREEN VISION BIOTECHNOLOGY CORP. with another company
What it owns
What GREEN VISION BIOTECHNOLOGY CORP. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $3.2M3 Dec 31, 2021 | $3.2M3 Dec 31, 2020 | +2.6% |
| Accumulated depreciation | $1.2M3 Dec 31, 2021 | $1.0M3 Dec 31, 2020 | +17.3% |
| Property and equipment, net | $2.1M3 Dec 31, 2021 | $2.2M3 Dec 31, 2020 | −4.1% |
Investments
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Accumulated amortization | -$448.5K3 Dec 31, 2021 | -$412.3K3 Dec 31, 2020 | −8.8% |
| Finite-lived intangibles, net | $818.4K3 Dec 31, 2021 | $822.0K3 Dec 31, 2020 | −0.4% |
Inventory
Leadership
Who has led GREEN VISION BIOTECHNOLOGY CORP., and when. Pick a name to see everywhere that person has worked.
- Chief executive officerChing Wan Lam Aug 7, 2017 to Feb 10, 202212
- Chief operating officerWai Kin Ma Aug 7, 2017 to Nov 30, 202013
Board members and other officers (4)
- Board memberKwong Tak Leung Sep 1, 2021 to Jan 25, 202214
- Board memberChing Wan Lam Aug 7, 2017 to Feb 10, 202212
- Board memberWai Kin Ma Aug 7, 2017 to Nov 30, 202013
- Board memberPhilip G. Allen Dec 15, 2015 to Dec 15, 201515
Former names
Timeline
Filings
19 filings to the SEC since October 2021: 2 annual reports, 3 quarterly reports, 3 major events, 2 insider forms, 9 other. The latest 19:
- Sep 30, 202215-15D 15-12D EDGAR
- Sep 19, 202210-K/A EDGAR
- Sep 14, 20228-K EDGAR
- Aug 22, 202210-Q EDGAR
- Aug 15, 2022NT 10-Q EDGAR
- Aug 8, 2022UPLOAD EDGAR
- Jul 21, 2022CORRESP EDGAR
- Jun 28, 2022UPLOAD EDGAR
- May 31, 2022CORRESP EDGAR
- May 23, 202210-Q EDGAR
- May 10, 2022NT 10-Q EDGAR
- May 5, 2022CORRESP EDGAR
- May 3, 20228-K EDGAR
- May 3, 2022UPLOAD EDGAR
- Mar 31, 202210-K EDGAR
- Feb 10, 20224 PRIMARY DOCUMENT EDGAR
- Jan 25, 20224 PRIMARY DOCUMENT EDGAR
- Jan 19, 20228-K EDGAR
- Nov 10, 202110-Q EDGAR
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
2 open-market trades by officers, directors and large owners since October 2021: 1 buys and 1 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jan 17, 2022 | LAM CHING WANCHIEF EXECUTIVE OFFICER | Buy | 75,674,200 | Form 4 | ||
| Jan 17, 2022 | LEUNG KWONG TAKDirector | Sale | 75,674,200 | Form 4 |
From Forms 4 filed with the SEC.
SEC filer profile
How GREEN VISION BIOTECHNOLOGY CORP. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARGREEN VISION BIOTECHNOLOGY CORP.1
- CIK0001571804
- Employer ID (EIN)98-10609411
- Filer statusNon-accelerated filer<br>smaller reporting company1
- Incorporated inNevada1
- Fiscal year endsDecember 311
- Industry code (SIC)2870 Agricultural Chemicals1
- Business addressRooms 1804-06, 18/F, Wing On House, 71 Des Voeux Road Central, Hong Kong Sar, F4 000001
- Phone852-949299671
- Shares outstanding160,790,000 as of Sep 19, 20223
- Public float$0 as of Sep 16, 20213
- On EDGAR sinceMay 3, 20131
- Filings98 in all: 10-Q (26), 8-K (11), UPLOAD (10), 10-K (9), CORRESP (8), NT 10-Q (7), S-1/A (6), 3 (4)1
All 19 form types
4 (3), NT 10-K (3), 5 (2), 8-K/A (2), 10-K/A (1), 10-Q/A (1), 10-QT (1), 15-15D (1), 8-A12G (1), EFFECT (1), S-1 (1)
- Latest filingsAnnual report (10-K) Mar 31, 2022
Quarterly report (10-Q) Aug 22, 2022
Latest 8-K (8-K) Sep 14, 2022
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13SEC EDGARWai Kin Ma, Chief operating officer
- 14SEC EDGARKwong Tak Leung, Board member
- 15SEC EDGARPhilip G. Allen, Board member
- 16SEC EDGAROther events
- 17SEC EDGAROther events
- 18SEC EDGARChange in control